Georgy Sagaradze/LinkedIn
Oct 5, 2025, 05:53
Georgy Sagaradze: A Billion-Dollar In Vitro Fertilization Opportunity?
Georgy Sagaradze, Head of Precision Oncology Division at BostonGene, shared a post on LinkedIn:
“A billion-dollar in vitro fertilization opportunity: time to focus on the male factor?
Historically, male infertility has received less attention in the global infertility challenge. Yet with in vitro fertilization (IVF) achieving success in only about 30% of cases, the paradigm is shifting toward addressing male factors as well. Key drivers include:
- Growing social acceptance of assisted reproduction
- Expanding scientific evidence on the mechanisms of male infertility
- Clinical practice moving from female-centric to both-partner focus
- Rising VC investment in male infertility startups
Today this is a ~$1B niche. But with later maternal age and declining sperm quality worldwide, the opportunities ahead may be substantial.
What’s your view?
I’m ready to contribute and collaborate — who’s in?”
-
Nov 2, 2026, 17:08Elena Milner: The 2nd Class of the School of Embryology Is Already in Full Swing
-
Nov 2, 2026, 17:05November Is National Diabetes Month – PCOS Awareness Association
-
Nov 2, 2026, 17:04Thanos Papathanasiou: Are We Preparing Patients for the IVF Cycle, or for the IVF Journey?
-
Nov 2, 2026, 17:02Anna Morales: Why Is It So Hard to Build in Women’s Health?
-
Nov 2, 2026, 16:59Rickard Ericsson: Honored to Take on the Role of Interim CEO of the Vitrolife Group
-
Nov 2, 2026, 16:56Mohammed Nasur: 1 Small Simulation, A Bigger Purpose
-
Nov 2, 2026, 16:54Carlos Guerrero: Presenting Our Latest Research on AI and Embryo Assessment at ASRM 2026
-
Nov 2, 2026, 16:52Sarah Lewen: My 1st ASRM Is Officially Complete
-
Nov 2, 2026, 16:49Jemma Garratt: Taking on the Role of Kind IVF and Data Science Manager at London Women’s Clinic